Patents by Inventor Andrea Rotgeri

Andrea Rotgeri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS
    Publication number: 20090099147
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I the use of the progesterone receptor modulators for producing medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: July 9, 2008
    Publication date: April 16, 2009
    Inventors: Wolfgnag SCHWEDE, Carsten Moeller, Anja Schmidt, Ulrike Fuhrmann, Andrea Rotgeri, Thomas Kirkland
  • NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS
    Publication number: 20090075989
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula 1, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: December 20, 2007
    Publication date: March 19, 2009
    Inventors: Wolfgang Schwede, Carsten Moeller, Anja Schmidt, Ulrike Fuhrmann, Andrea Rotgeri, Thomas Andrew Kirkland, Ralf Wyrwa
  • NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS
    Publication number: 20080188448
    Abstract: The present invention relates to non-steroidal progesterone receptor modulators of the general formula I, the use of the progesterone receptor modulators for the manufacture of medicaments, and pharmaceutical compositions which comprise these compounds. The compounds according to the invention are suitable for the therapy and prophylaxis of gynaecological disorders such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding and dysmenorrhoea, and for the therapy and prophylaxis of hormone-dependent tumours and for use for female fertility control and for hormone replacement therapy.
    Type: Application
    Filed: December 20, 2007
    Publication date: August 7, 2008
    Inventors: Wolfgang Schwede, Thomas Andrew Kirkland, Anja Schmidt, Ulrike Fuhrmann, Carsten Moeller, Andrea Rotgeri
  • New effector conjugates, methods for their preparation and their pharmaceutical use
    Publication number: 20060276413
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable saccharides or saccharide derivatives (as recognition units) are described. Their production is carried out by the recognition units being reacted with suitable linkers, and the compounds that are produced are conjugated to the effectors. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Application
    Filed: August 8, 2006
    Publication date: December 7, 2006
    Inventors: Klaus Bosslet, Holger Hess-Stumpp, Jens Hoffmann, Ulrich Klar, Andrea Rotgeri
  • Effector conjugates, methods for their preparation and their pharmaceutical use
    Publication number: 20040167083
    Abstract: Conjugates of epothilones and epothilone derivatives (as effectors) with suitable saccharides or saccharide derivatives (as recognition units) are described. Their production is carried out by the recognition units being reacted with suitable linkers, and the compounds that are produced are conjugated to the effectors. The pharmaceutical use of the conjugates for treating proliferative or angiogenesis-associated processes is described.
    Type: Application
    Filed: December 5, 2003
    Publication date: August 26, 2004
    Inventors: Klaus Bosslet, Holger Hess-Stumpp, Jens Hoffmann, Ulrich Klar, Andrea Rotgeri
  • Use of Epothilones in the treatment of brain diseases associated with proliferative processes
    Publication number: 20040019088
    Abstract: This invention provides the use of an Epothilone, which shows an average distribution coefficient between plasma and brain of 0.3 to 1.5 in the mouse intravenous bolus injection assay, for the preparation of a medicament for the treatment of a brain disease associated with proliferative processes.
    Type: Application
    Filed: February 28, 2003
    Publication date: January 29, 2004
    Applicant: Schering AG
    Inventors: Rosemarie Lichtner, Andrea Rotgeri, Ulrich Klar, Jens Hoffmann, Bernd Buchmann, Wolfgang Schwede, Werner Skuballa